SK
ABBV icon

Sarah Ketterer’s AbbVie ABBV Stock Holding History

Sarah Ketterer’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-213,613
Closed -$38.9M – 91
2024
Q1 		$38.9M Sell
213,613
-189,253
-47% -$32.6M 1.02% 32
2023
Q4 		$62.4M Buy
402,866
+5,683
+1% +$829K 1.59% 18
2023
Q3 		$59.2M Buy
397,183
+58,123
+17% +$8.53M 1.56% 15
2023
Q2 		$45.7M Buy
+339,060
New +$49.7M 1.2% 21

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sarah Ketterer's ABBV Position: Q2 2024 in Review

Sarah Ketterer sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 213,613 shares — an estimated $38.9M sold.

Sarah Ketterer first reported a position in ABBV in Q2 2023 and held it in 4 quarters. The position peaked at $62.4M in Q4 2023. 3,369 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Sarah Ketterer reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Sarah Ketterer sold 213,613 AbbVie shares in Q2 2024, an estimated $38.9M.
  • Sarah Ketterer first reported a position in AbbVie in Q2 2023 and held it in 4 quarters.
  • Sarah Ketterer's AbbVie position peaked at $62.4M in Q4 2023.
  • 3,369 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Causeway Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.